Table 1.
Presence of the considered lesion | Absence of the considered lesion | ||||||
---|---|---|---|---|---|---|---|
Histological changes | No. of samples | Mean ± SD | Median | Range | Mean ± SD | Median | Range |
No relevant findings | 21 | 49.88 ± 18.7 | 41.24 | 26.9–93.8 | 47.96 ± 21.42 | 38.76 | 16.16–94.76 |
Glomerulosclerosis | 33 | 47.79 ± 22.88 | 37.7 | 16.1–94.7 | 48,68 ± 18.67 | 41.36 | 25.47–93.08 |
Tubular atrophy* | 11 | 66.8 ± 21.78 | 66.94 | 31.42–94.76 | 44.93 ± 18.63 | 37.77 | 16.13–93.08 |
Fibrosis | 12 | 51.83 ± 27.68 | 44.54 | 20.23–94.76 | 47.53 ± 19.04 | 40.07 | 16.16–93.08 |
Glomerular atrophy | 10 | 48.16 ± 20.94 | 41.16 | 25.69–77.35 | 48.29 ± 20.76 | 40.91 | 16.16–94.76 |
Interstitial nephritis | 23 | 48.94 ± 22.61 | 44.03 | 20.23–94.76 | 47.96 ± 19.76 | 39.54 | 16.16–93.08 |
Glomerulonephritis | 9 | 37.34 ± 8.75 | 35.52 | 25.69–49.36 | 49.83 ± 21.31 | 41.63 | 16.16–94.76 |
Neoplasia | 5 | 33.05 ± 6.7 | 33.69 | 25.47–41.63 | 49.20 ± 20.81 | 44.03 | 16.16–94.76 |
*Statistically significant differences –p < 0,05